Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-11-12
pubmed:abstractText
Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central nervous system lymphoma. Because it is rare and difficult to diagnose, the natural history and optimal management are unknown.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1851-5
pubmed:meshHeading
pubmed-meshheading:17804469-Adult, pubmed-meshheading:17804469-Aged, pubmed-meshheading:17804469-Aged, 80 and over, pubmed-meshheading:17804469-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17804469-Central Nervous System Neoplasms, pubmed-meshheading:17804469-Combined Modality Therapy, pubmed-meshheading:17804469-Consensus, pubmed-meshheading:17804469-Eye Neoplasms, pubmed-meshheading:17804469-Female, pubmed-meshheading:17804469-HIV Seronegativity, pubmed-meshheading:17804469-Humans, pubmed-meshheading:17804469-Lymphoma, Non-Hodgkin, pubmed-meshheading:17804469-Male, pubmed-meshheading:17804469-Middle Aged, pubmed-meshheading:17804469-Neoplasm Recurrence, Local, pubmed-meshheading:17804469-Neoplasm Staging, pubmed-meshheading:17804469-Prognosis, pubmed-meshheading:17804469-Radiotherapy, Adjuvant, pubmed-meshheading:17804469-Retrospective Studies, pubmed-meshheading:17804469-Risk Assessment, pubmed-meshheading:17804469-Survival Analysis, pubmed-meshheading:17804469-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
pubmed:affiliation
Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
pubmed:publicationType
Journal Article, Multicenter Study